SfN meetings gather thousands of neuroscientists from around the world to debut cutting-edge research on the brain and nervous system. PrecisionLife will be attending to share some of our latest precision neuroscience research.
At SfN, PrecisionLife Data Scientist, Karolina Chocian, will present Cross disorder patient and mechanistic stratification using combinatorial analyses.
Poster Title: Cross Disorder Patient and Mechanistic Stratification using Combinatorial Analyses
Session Title: Genetic Techniques to Target and/or Manipulate Cells
Poster Number: 178.30
Session Number: 178
Presentation Time: 2pm - 3pm on Sunday 12 November
Posterboard Number: VV32
Authors: S. Hogg, K. Chocian, S. Das, A. Malinowski, K. Taylor, S. Beaulah
To see the agenda and register, visit the SfN website.
PrecisionLife focuses on precision medicine analytics in complex chronic diseases, including CNS, autoimmune, cardiovascular, respiratory and metabolic diseases. We have multiple strategic R&D collaborations with biopharma companies, and have generated deep disease insights in 50 diseases.
We map novel targets to specific patient subgroups with causal genetic and mechanistic explanations and disease prelevance. Our patient stratification biomarkers help design smaller, faster, more targeted clinical trials and to build highly predictive complementary diagnostics. We also work with biopharma companies to reevaluate clinical trial results, identify secondary indications and out-licensing opportunities for pipeline and/or stalled assets.
Contact us to learn more about PrecisionLife